86 related articles for article (PubMed ID: 1234054)
1. Use of formalin-fixed melanoma cells for the detection of antibodies against surface antigens by a micro-immune adherence technique.
Müller C; Sorg C
Eur J Immunol; 1975 Mar; 5(3):175-8. PubMed ID: 1234054
[TBL] [Abstract][Full Text] [Related]
2. Membrane associated antigens of human malignant melanoma. II. Leucocyte migration studies with formalin fixed human melanoma cells.
Suter L; Sorg C; Macher E
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):242-9. PubMed ID: 134542
[TBL] [Abstract][Full Text] [Related]
3. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
[TBL] [Abstract][Full Text] [Related]
4. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
Watanabe T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
6. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
[No Abstract] [Full Text] [Related]
7. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
Takeyama H; Watanabe T; Livingston PO
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
[TBL] [Abstract][Full Text] [Related]
8. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line.
Gupta RK; Irie RF; Chee DO; Kern DH; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):347-56. PubMed ID: 88538
[No Abstract] [Full Text] [Related]
10. Immunological block to synthetic alpha-melanocyte-stimulating hormone: melanocyte interaction by antibodies isolated from cell-column immunoadsorbents.
Winkelhake JL; Elcombe BM; Hodach A
Cancer Res; 1979 Aug; 39(8):3058-64. PubMed ID: 455290
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
12. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
[TBL] [Abstract][Full Text] [Related]
13. Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatment.
Ioannides CG; Platsoucas CD; Bowen JM; Wharton JT; Freedman RS
Anticancer Res; 1989; 9(1):81-6. PubMed ID: 2705759
[TBL] [Abstract][Full Text] [Related]
14. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
Imai K; Ferrone S
Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
16. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
17. Autologous antibodies to meningioma cell surface antigens.
Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
19. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
20. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
